Evidence map›Paper›PMID 27891224›Full record

ArticleImmunity, inflammation and disease2016

TCR signaling by conventional CD4

Theresa M Leichner, Atsushi Satake, Taku Kambayashi

Open access · goldAbstract read
In one paragraph

Article in Immunity, inflammation and disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Theresa M LeichnerDepartment of Pathology and Laboratory Medicine Perelman School of Medicine at the University of Pennsylvania Philadelphia PA 19104 USA.
Atsushi SatakeFirst Department of Internal Medicine Kansai Medical University Moriguchi Osaka Japan.
Taku KambayashiDepartment of Pathology and Laboratory Medicine Perelman School of Medicine at the University of Pennsylvania Philadelphia PA 19104 USA.
University of Pennsylvania · USKansai Medical University · JP

Funding

The role of the T cell receptor in regulatory T cell homeostasis and expansionR01HL111501 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI KAMBAYASHI, TAKU · 2012 to 2020
$3.6M
Proximal signaling complexes in NK cell effector function and developmentR01HL107589 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI KAMBAYASHI, TAKU · 2011 to 2015
$2.0M
Separation of GVHD and GVT effects by a TCR signaling mutationR21AI117282 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI JORDAN, MARTHA S, KAMBAYASHI, TAKU · 2015 to 2016
$440k
NHLBI NIH HHS R01 HL107589NHLBI NIH HHS R01 HL111501NIAID NIH HHS R21 AI117282
6 · The paper itself

Abstract

To maintain immune tolerance, regulatory T cell (Treg) numbers must be closely indexed to the number of conventional T cells (Tconvs) so that an adequate Treg:Tconv ratio can be maintained. Two factors important in this process are the cytokine interleukin-2 (IL-2) and T cell receptor (TCR) stimulation by major histocompatibility complex class II (MHC-II). Here, we report that in addition to TCR stimulation of Tregs themselves, the maintenance of Tregs also requires TCR signaling by Tconvs. We found that Tconvs produce IL-2 in response to self-peptide-MHC-II complexes and that Tconvs possessing more highly self-reactive TCRs express more IL-2 at baseline. Furthermore, selective disruption of TCR signaling in Tconvs led to a trend toward decreased expression of IL-2 and attenuated their ability to maintain Treg numbers. These data suggest that in order to maintain an adequate Treg:Tconv ratio, Tregs are continuously indexed to self-peptide-MHC-II-induced TCR signaling of Tconvs. These results have implications in attempts to modulate immune tolerance, as Treg numbers adjust to the self-reactivity, and ultimately IL-2 production by the T cells around them.

Indexed as

Immune ToleranceAnimalsCD4-Positive T-LymphocytesForkhead Transcription FactorsInterleukin-2Lymphocyte ActivationMiceMice, Inbred C57BLMice, TransgenicReceptors, Antigen, T-CellT-Lymphocytes, RegulatoryForkhead Transcription FactorsInterleukin-2Receptors, Antigen, T-CellHomeostasisIL‐2indexingregulatory T cell

Identifiers

PMID27891224
PMCPMC4879461
OpenAlexW2304714177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.